A human genome editing-based MLL::AF4 ALL model recapitulates key cellular and molecular leukemogenic features.


Por: Bueno C, Torres-Ruíz R, Velasco-Hernandez T, Molina O, Petazzi P, Martinez-Moreno A, Rodríguez-Cortez VC, Vinyoles M, Cantilena S, Williams O, Vega-García N, Rodriguez-Perales S, Segovia JC, Quintana-Bustamante O, Roy A, Meyer C, Marschalek R, Smith A, Milne TA, Fraga MF, Tejedor JRR and Menendez P

Publicada: 16 nov 2023 Ahead of Print: 1 nov 2023
Resumen:
Cellular ontogeny and MLL breakpoint site influence the capacity of MLL-edited CD34+ hematopoietic cells to initiate and recapitulate infant patients' features in pro-B-cell acute lymphoblastic leukemia (B-ALL). We provide key insights into the leukemogenic determinants of MLL-AF4+ infant B-ALL.

Filiaciones:
Bueno C:
 Josep Carreras Leukemia Research Institute, Barcelona, Spain

Torres-Ruíz R:
 CNIO, Spain

Velasco-Hernandez T:
 Josep Carreras Leukemia Research Institute., Barcelona, Spain

Molina O:
 Josep Carreras Leukemia Research Institute, Barcelona, Spain

Petazzi P:
 Josep Carreras Leukemia Research Institute, Barcelona, Spain

Martinez-Moreno A:
 Josep Carreras Leukaemia Research Institute, Department of Biomedicine, School of Medicine,, Barcelona, Spain

Rodríguez-Cortez VC:
 Josep Carreras Leukemia Research Institute, Barcelona, Spain

Vinyoles M:
 Josep Carreras Leukemia Research Institute, Barcelona, Spain

Cantilena S:
 UCL Institute of Child Health, London, United Kingdom

Williams O:
 UCL Institute of Child Health, London, United Kingdom

Vega-García N:
 Haematology Laboratory, Institut de Recerca Hospital Sant Joan de Déu, Esplugues de Llobregat, Barcelona, Spain

Rodriguez-Perales S:
 CNIO, Madrid, Spain

Segovia JC:
 Biomedical Innovation Unit, Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas (CIEMAT) and Centro de Investigación Biomédica en Red de Enfermedades R, MADRID, Spain

Quintana-Bustamante O:
 CIEMAT/CIBERER/IIS-FJD, Madrid, Spain

Roy A:
 University of Oxford, Oxford, United Kingdom

Meyer C:
 DCAL, Institute of Pharmaceutical Biology, Goethe-University Frankfurt, Frankfurt/M, Germany

Marschalek R:
 Goethe-University of Frankfurt/Main, Frankfurt, Germany

Smith A:
 Weatherall Institute of Molecular Medicine, Oxford, United Kingdom

Milne TA:
 University of Oxford, Oxford, United Kingdom

Fraga MF:
 Centro de Investigación Biomédica en Red Enfermedades Raras (CIBERER), Spain

Tejedor JRR:
 Centro de Investigación Biomédica en Red Enfermedades Raras (CIBERER), Spain

Menendez P:
 Institut Català de Recerca i Estudis Avançats (ICREA), Spain
ISSN: 00064971





BLOOD
Editorial
ELSEVIER, RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS, Estados Unidos America
Tipo de documento: Letter
Volumen: 142 Número: 20
Páginas: 1752-1756
WOS Id: 001120940200001
ID de PubMed: 37756522
imagen Green Published, hybrid

MÉTRICAS